Black Diamond Therapeutics (BDTX)
(Delayed Data from NSDQ)
$5.11 USD
+0.05 (0.99%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $5.12 +0.01 (0.20%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.44 | 6.90% |
Earnings Summary
For their last quarter, Black Diamond Therapeutics (BDTX) reported earnings of -$0.34 per share, beating the Zacks Consensus Estimate of $-0.47 per share. This reflects a positive earnings surprise of 27.66%. Look out for BDTX's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.44 per share, reflecting a year-over-year increase of 22.81%.
Earnings History
Price & Consensus
Zacks News for BDTX
Black Diamond (BDTX) Upgraded to Buy: What Does It Mean for the Stock?
BDTX: What are Zacks experts saying now?
Zacks Private Portfolio Services